Northeast Financial Consultants »

Cognition Therapeutics shares owned by Northeast Financial Consultants

Quarter-by-quarter ownership of Cognition Therapeutics (CGTX) shares owned by Northeast Financial Consultants from 13F filings

Historical chart of Northeast Financial Consultants investment in Cognition Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cognition Therapeutics held by Northeast Financial Consultants consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cognition Therapeutics by Northeast Financial Consultants

Quarter filed Position value Share count Share price at filing
2025-06-30 $20k 63k 0.31
2025-03-31 $27k 63k 0.42
2024-12-31 $17k 25k 0.70
2024-09-30 $12k 25k 0.47
2024-06-30 $41k 25k 1.66
2024-03-31 $45k 25k 1.82
2023-12-31 $45k 25k 1.85
2023-09-30 $35k 25k 1.44
2023-06-30 $45k 25k 1.83
2023-03-31 $49k 25k 1.98
2022-12-31 $52k 25k 2.10

More positions owned by Northeast Financial Consultants

Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Specialized Funds Div App Etf (VIG)
Blackstone Secd Lending Common Stock (BXSL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core Div Grwth (DGRO)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Vanguard Whitehall Fds High Div Yld (VYM)
Golub Capital BDC (GBDC)
Apple (AAPL)
First Tr Exchange-traded Dj Internt Idx (FDN)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Northeast Financial Consultants

Top funds holding Cognition Therapeutics

BIOS Capital Management
Vanguard Group
Davenport & Co
Tang Capital Management
Chescapmanager
BlackRock
Jane Street
Renaissance Technologies
Geode Capital Management
Hilton Capital Management
Millennium Management
State Street Corporation
Voss Capital
Graham Capital Management
Sigma Planning

View all funds holding Cognition Therapeutics